Loading clinical trials...
Loading clinical trials...
This is a randomized, double-blinded pilot study to determine whether patients undergoing ambulatory total knee arthroplasty (TKA) using a subvastus approach benefit from the addition of a continuous adductor canal nerve block (cACB) catheter along with an existing multimodal approach to postoperative analgesia. Outcomes include the 15-item Quality of Recovery Scale (QoR-15) (Miles 2016), pain scores, opioid consumption, opioid-free days, functional outcome as measured by the Time Up and Go (TUG) test, patient satisfaction, patient's rating of catheter effectiveness, and complications.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
The Ottawa Hospital, General Campus
Ottawa, Ontario, Canada
Start Date
May 2, 2017
Primary Completion Date
April 1, 2020
Completion Date
April 1, 2020
Last Updated
December 22, 2020
81
ACTUAL participants
Normal Saline
DRUG
Ropivacaine
DRUG
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
NCT07388953
NCT07301528
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions